Osartil 50mg

Osartil

Losartan Potassium tablet

Presentation

Osartil 25 Each tablet contains Losartan Possumus 25 mg

Osartil 50: Each tablet contains Losartan Potassium USP 50 mg

Osartil 100: Each tablet contains Losartan Potassium USP 100 mg

Description

Losartan, the first of a new class of antihypertensives. is an angiotensin II receptor (type AT1) antagonist. Angiotensin II is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. Losartan and its principal active metabolite block the vasoconstriction and aldosterono secreting effects of angiotensin 11 by selectively blocking the binding of angiotensin 11 to the AT1 receptor found in many tissues. Osartil is now regarded as the first-line therapy option for treating high blood pressure.

Indications

Losartan is indicated for the treatment of all grades of hypertension, Chronic heart failure, Stroke risk reduction in hypertension & LVH and Nephropathy in type 2 Diabetes. It may be used alone or in combination with other antihypertensive agents. It is an alternative for patients who have to discontinue an ACE inhibitor because of persistent dry cough.

Dosage and Administration

Hypertension: The usual starting dose is 50 mg once daily. In patients with possible depletion of intravascular volume or patients with a history of hepatic impairment, starting dose is 25 mg once daily. Losartan can be administered once or twice daily with total daily doses ranging from 25 mg to 100 mg. No initial dosage adjustment is necessary for elderly or renal impairment patients. If blood pressure is not controlled by Losartan, a low dose of a diuretic (Hydrochlorothiazide) may be added. Losartan may be administered with or without food. Chronic heart failure: 12.5 mg once daily, increased at weekly intervals to 50 mg once daily it tolerated. Stroke risk reduction in hypertension & LVH: 50 mg once daily. Hydrochlorothiazide 12.5 mg daily should Maximum dose-Losartan 100 mg followed by Hydrochlorothiazide 25 mg once daily. Nephropathy in type 2 Diabetes: 50 mg once daily. Maximum dose-100 mg once daily.

Side effects

Overall incidence of adverse effects of Losartan is comparable to placebo in clinica studies. The most common adverse events occuring with Losartan at a rate of >19 above placebo were upper respiratory infection (7.9% vs 6.9%), dizziness (3.5% 2.1%) and leg pain (1.0% vs 0.0%).

Precautions

Losartan should be used with caution in patients with hypersensitivity to drugs that act through renin-angiotensin system. Special precaution should be ta when it is administered to the patients with renal and hepatic impairment. Safety effectivenss of Losartan in pediatric patients have not been established.

Contraindications

Losartan is contraindicated in patients who are hypersensitive to the active ingred

or any component of the drug. Use in Pregnancy and Lactation

Losartan must be discontinued as soon as possible when pregnancy is detected should not be prescribed during lactation as there is no information in humans on

passage of Losartan into breast milk.

Drug interactions

No drug interactions of clinical significance have been identified. Drugs which H been studied in clinical pharmacokinetic trials include (1) Hydrochlorothiazide Digoxin, (3) Warfarin, (4) Cimetidine, (5) Ketoconazole and (6) Phenobarbital.

Storage

Do not store above 30°C. Keep out of the reach of children.

Manufactured by

Incepta Pharmaceuticals Ltd.

Savar, Dhaka, Bangladesh.